Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 175 participants.

Also called NCT05164107

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 175 participants (planned count) (from the registry)
Sponsor
  • Kardium Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05164107
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05164107. Allocation not applicable; no masking; primary purpose other. Start 2021-12-08 (actual); primary completion 2027-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
Acronym
PULSE-EU
Intervention (Device)
Globe Mapping and Pulsed Field Ablation System (Globe PF System)
Lead sponsor
Kardium Inc. (class: industry)

Record details

Record id
cardio:ct-nct05164107
Content hash
250b43366bb7026147a8054b699797d96a71f4381826d3648f10c6512e5c9713